INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 201 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $17,000 | -5.6% | 736 | 0.0% | 0.00% | – |
| Q4 2020 | $18,000 | -51.4% | 736 | -18.0% | 0.00% | – |
| Q3 2020 | $37,000 | -21.3% | 898 | -7.7% | 0.00% | – |
| Q2 2020 | $47,000 | -31.9% | 973 | -11.4% | 0.00% | – |
| Q1 2020 | $69,000 | -51.1% | 1,098 | -3.5% | 0.00% | -100.0% |
| Q4 2019 | $141,000 | +187.8% | 1,138 | +54.6% | 0.00% | – |
| Q3 2019 | $49,000 | -16.9% | 736 | 0.0% | 0.00% | – |
| Q2 2019 | $59,000 | -28.0% | 736 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $82,000 | +10.8% | 736 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $74,000 | -20.4% | 736 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $93,000 | +50.0% | 736 | 0.0% | 0.00% | – |
| Q2 2018 | $62,000 | +37.8% | 736 | 0.0% | 0.00% | – |
| Q1 2018 | $45,000 | +4.7% | 736 | 0.0% | 0.00% | – |
| Q4 2017 | $43,000 | -65.6% | 736 | -66.0% | 0.00% | -100.0% |
| Q3 2017 | $125,000 | +7.8% | 2,162 | +124.7% | 0.00% | 0.0% |
| Q2 2017 | $116,000 | +6.4% | 962 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $109,000 | -13.5% | 962 | -16.9% | 0.00% | 0.0% |
| Q4 2016 | $126,000 | +281.8% | 1,158 | +484.8% | 0.00% | – |
| Q3 2016 | $33,000 | +3200.0% | 198 | +2100.0% | 0.00% | – |
| Q1 2016 | $1,000 | -98.8% | 9 | -98.4% | 0.00% | -100.0% |
| Q4 2015 | $84,000 | -13.4% | 560 | -3.8% | 0.00% | 0.0% |
| Q3 2015 | $97,000 | -34.0% | 582 | -4.4% | 0.00% | 0.0% |
| Q2 2015 | $147,000 | +1.4% | 609 | +18.5% | 0.00% | 0.0% |
| Q1 2015 | $145,000 | +34.3% | 514 | -26.0% | 0.00% | 0.0% |
| Q4 2014 | $108,000 | -4.4% | 695 | +45.7% | 0.00% | 0.0% |
| Q3 2014 | $113,000 | +44.9% | 477 | +45.4% | 0.00% | 0.0% |
| Q2 2014 | $78,000 | +6.8% | 328 | +47.7% | 0.00% | 0.0% |
| Q1 2014 | $73,000 | +73.8% | 222 | -63.7% | 0.00% | – |
| Q4 2013 | $42,000 | – | 611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |